NCT06566313Completed
An Open-label Study on the Clinical Efficacy of tDCS Intervention in PD
Source: ClinicalTrials.gov · Last updated 18 Dec 2024
Brief summary (registry, in English)
To demonstrate that intervention targeting the primary motor area (M1) using transcranial Direct Current Stimulation can improve sleep symptoms in patients with Parkinson's disease.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 17 (actual)
- First submitted
- 20 Aug 2024
- Start date
- 1 Jan 2021
- Primary completion date
- 31 Dec 2022
- Lead sponsor
- Anhui Medical University
- Diseases
- Parkinson disease
- NCT number
- NCT06566313
What you commit to
- Study type: Interventional
- Participants enrolled: 17
- From 1 Jan 2021 to the primary completion date, 31 Dec 2022
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- The presence of other serious mental illness (such as major depression, psychosis or obsessive-compulsive disorder, physical illness or a history of substance abuse);
- Have a head injury, stroke or other neurological disorder;
- The diagnosis of PD dementia is difficult to complete the assessment.
Other
- The patient has a metal object or skull brace device or any similar metal object on the scalp;
- Head tremor or limb shaking is so severe that it is difficult to calmly receive treatment;
Who the study is looking for
- The diagnosis of PD was determined by neurologists with rich clinical work experience, and was in line with the diagnostic criteria for Parkinson's disease in China (2016 edition).
- The total score of RBD Screening Questionnaire (RBDSQ) is ≥6 points.
- All patients took the drug stably and had no history of drug adjustment within 2 months before treatment. The test was conducted 2 hours after taking the drug.
- Good compatibility, with a certain degree of compliance;
- Normal mental condition, able to cooperate with behavioral tests and transcranial electrical stimulation treatment;
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Cognitive Neuropsychology Lab Anhui Medical University Coordinator of this site? Confirm its status | Hefei | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.